Historical Valuation
IVD MEDICAL (01931) is now in the Fair zone, suggesting that its current forward PE ratio of 5.07 is considered Fairly compared with the five-year average of 6.33. The fair price of IVD MEDICAL (01931) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：2.18
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
IVD MEDICAL (01931) has a current Price-to-Book (P/B) ratio of 1.01. Compared to its 3-year average P/B ratio of 0.99 , the current P/B ratio is approximately 1.29% higher. Relative to its 5-year average P/B ratio of 1.00, the current P/B ratio is about 0.65% higher. IVD MEDICAL (01931) has a Forward Free Cash Flow (FCF) yield of approximately -49.60%. Compared to its 3-year average FCF yield of 8.00%, the current FCF yield is approximately -720.08% lower. Relative to its 5-year average FCF yield of 7.13% , the current FCF yield is about -795.36% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 01931 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 01931 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 01931 currently overvalued or undervalued?
IVD MEDICAL (01931) is now in the Fair zone, suggesting that its current forward PE ratio of 5.07 is considered Fairly compared with the five-year average of 6.33. The fair price of IVD MEDICAL (01931) is between to according to relative valuation methord.
What is IVD MEDICAL (01931) fair value?
01931's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of IVD MEDICAL (01931) is between to according to relative valuation methord.
How does 01931's valuation metrics compare to the industry average?
The average P/S ratio for 01931's competitors is , providing a benchmark for relative valuation. IVD MEDICAL Corp (01931) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for IVD MEDICAL (01931) as of Jan 16 2026?
As of Jan 16 2026, IVD MEDICAL (01931) has a P/B ratio of 1.01. This indicates that the market values 01931 at 1.01 times its book value.
What is the current FCF Yield for IVD MEDICAL (01931) as of Jan 16 2026?
As of Jan 16 2026, IVD MEDICAL (01931) has a FCF Yield of -49.60%. This means that for every dollar of IVD MEDICAL’s market capitalization, the company generates -49.60 cents in free cash flow.
What is the current Forward P/E ratio for IVD MEDICAL (01931) as of Jan 16 2026?
As of Jan 16 2026, IVD MEDICAL (01931) has a Forward P/E ratio of 5.07. This means the market is willing to pay $5.07 for every dollar of IVD MEDICAL’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for IVD MEDICAL (01931) as of Jan 16 2026?
As of Jan 16 2026, IVD MEDICAL (01931) has a Forward P/S ratio of 0.77. This means the market is valuing 01931 at $0.77 for every dollar of expected revenue over the next 12 months.